Maternal RSV immunization creates an important opportunity for obstetric and pediatric clinicians to coordinate newborn prevention strategies, according to Kevin Ault, MD.
|Podcasts|November 4, 2020
S2E6: Vaginal dilators with Dr. Michael Krychman
Author(s)Lindsey Carr, Editor
Dr. Krychman is a gynecologist who specializes in sexual health and survivorship medicine. He is executive director of the Southern California Center for Sexual Health and Survivorship Medicine Inc. in Newport Beach, Calif.
Advertisement
In this episode of Pap Talk, Senior Editor Angie DeRosa interviewed Dr. Michael Krychman to discuss vaginal dilators in preparation for his feature article in the
Stay tuned for the full, peer-reviewed article and watch the video
Advertisement
Related to this article
A new Gallup survey found 51% of women in the United States reported negative healthcare experiences.
Hugh Taylor, MD, explains that imaging in endometriosis is best for ruling out other causes of pelvic pain and cannot exclude the diagnosis.
A new study links earlier menopause age to faster cognitive decline and earlier Alzheimer diagnosis.
The FDA office of Women's Health and Center for Drug Evaluation and Research and hosting a public workshop with a focus on testosterone use in menopausal women.
Bruce Dorr, MD, FACOG, URPS, FMCP-M, weighs his own experience with pellet therapy against guideline evidence, then he and Maria Uloko, MD, close with candid advice for clinicians too afraid of hormones to start prescribing.
Bruce Dorr, MD, FACOG, URPS, FMCP-M, and Maria Uloko, MD, walk through real-world dosing, cost workarounds, and the labs that actually matter for safety and efficacy.
Bruce Dorr, MD, FACOG, URPS, FMCP-M, and Maria Uloko, MD, reframe testosterone candidacy around clinical presentation and hormone state, not age cutoffs or a single number on a chart.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Off-label testosterone dosing, access, and lab monitoring in the US
2
Survey: 51% of US-women report negative healthcare experiences
3
FDA holding public meeting on testosterone use in menopausal women
4
Pellet therapy and practical advice for hesitant prescribers
5